Restoring the function of mutated tumor suppressor genes is a significant challenge in cancer therapy. However, there are promising approaches. One strategy involves using small molecules to reactivate mutated p53 proteins. Another approach is gene therapy, where a normal copy of the tumor suppressor gene is delivered to the cancer cells. These therapies are still largely experimental but offer hope for future cancer treatments.
